Evidence map›Paper›PMID 39201671›Full record

ArticleInternational journal of molecular sciences2024

Ethyl Acetate Fractions of

Yung-Chien Hsu, Ya-Hsueh Shih, Cheng Ho, Cheng-Chi Liu, Chia-Ching Liaw, Hui-Yi Lin, Chun-Liang Lin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yung-Chien HsuDepartments of Nephrology, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
Ya-Hsueh ShihDepartments of Nephrology, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
Cheng HoKidney and Diabetic Complications Research Team (KDCRT), Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
Cheng-Chi LiuDepartments of Nephrology, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
Chia-Ching LiawNational Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei 112304, Taiwan.ORCID 0000-0001-5642-4679
Hui-Yi LinSchool of Pharmacy, China Medical University, Taichung 406040, Taiwan.ORCID 0000-0001-8266-908X
Chun-Liang LinDepartments of Nephrology, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.ORCID 0000-0002-5710-8405

Funding

Chiayi Chang Gung Memorial Hospital CMRPG6J0301-3National Science and Technology Council institution MMRPG
6 · The paper itself

Abstract

Diabetic nephropathy, a leading cause of end-stage renal disease, accounts for significant morbidity and mortality. It is characterized by microinflammation in the glomeruli and myofibroblast activation in the tubulointerstitium.

Indexed as

AcetatesDiabetes Mellitus, ExperimentalDiabetic NephropathiesDrugs, Chinese HerbalFibrosisPPAR gammaSalvia miltiorrhizaAnimalsFibronectinsGlucoseMaleMesangial CellsMiceMice, Inbred C57BLPlant ExtractsPPAR alphaAcetatesdan-shen root extractDrugs, Chinese Herbalethyl acetateFibronectinsGlucosePlant ExtractsPPAR alphaPPAR gammaTransforming Growth Factor beta1diabetic nephropathyethyl acetate layermesangial cellsmyofibroblast activationrenal fibrosisSalvia miltiorrhiza

Identifiers

PMID39201671
PMCPMC11354680

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.